New Research Into How Oral GLP-1s Act in the Brain A study published in the journal Nature on 6 May 2026 offered a further dimension to the oral versus injectable debate
Recent research suggests that medications for type 2 diabetes of the GLP-1 class, such as Ozempic or Mounjaro, could offer an additional benefit beyond glycemic control: reduce the risk of dangerous blood clots in people with diabetes.This finding represents a new potential advantage for those who use these treatments
doi: 10.1074/jbc.M110.164392 103 NovgorodovS
DataM segments the market by product type, Carbon Farming Market to Reach US$ 492.66 Million by 2035 as Carbon Credits, Reg The global Carbon Farming Market reached US$ 129.56 million in 2025 and is expected to reach US$ 492.66 million by 2035, growing at a 14.29% CAGR during 2026-2035, according to DataM Intelligence
Before supporting MTHFR, it is important to lay some ground work and set the foundation for detoxification which is significantly reduced with the MTHFR gene
